Potent antitumor and antineoplastic efficacy of baicalein on benzo(a)pyrene-induced experimental pulmonary tumorigenesis

Fundamental and Clinical Pharmacology

Volumn 26, Issue 2, 2012, Pages 259-270

  Naveenkumar, Chandrashekar ^a   Asokkumar, Selvamani ^a   Raghunandhakumar, Subramanian ^a   Jagan, Sundaram ^a   Anandakumar, Pandi ^a   Augustine, Titto Alby ^a   Kamaraj, Sattu ^a   Devaki, Thiruvengadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Baicalein; Benzo(a)pyrene; Chemoprevention; Neoplastic lesions; Pulmonary tumorigenesis

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DEAMINASE; BAICALEIN; BENZO[A]PYRENE; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; TUMOR MARKER; UNSPECIFIC MONOOXYGENASE;

ANAPLASTIC CARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY WEIGHT; CANCER GROWTH; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HYPERPLASIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DYSPLASIA; LUNG HOMOGENATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; TOBACCO; TUMOR LOCALIZATION; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZO(A)PYRENE; DISEASE PROGRESSION; FLAVANONES; LUNG NEOPLASMS; MALE; MICE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858066600     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00910.x     Document Type: Article

References (63)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer (2001) 94 153-156.
2. Parkin D.M., Pisani P., Ferlay J. Global cancer statistics. CA Cancer J. Clin. (1999) 49 33-64.
3. Minna J.D., Roth J.A., Gazdar A.F. Focus on lung cancer. Cancer Cell (2002) 1 49-52.
4. Maggiore C., Mule A., Fadda G. et al. Histological classification of lung cancer. Rays. (2004) 29 353-355.
5. Dipple A., Khan Q.A., Page J.E., Ponten I., Szeliga J. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens. Int. J. Oncol. (1999) 14 103-111.
6. Szeliga J., Dipple A. DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. (1998) 11 1-11.
7. Sullivan P.D. Free radicals of Benzo(a)pyrene and derivatives. Environ. Health prospect. (1985) 64 283-295.
8. Thiery-Vuillemin A., Nguyen T., Pivot X., Spano J.P., Dufresnne A., Soria J.C. Molecular targeted agents: their promise as cancer chemopreventive interventions. Eur. J. Cancer (2005) 41 2003-2015.
9. Greenwald P. Science, medicine, and the future: cancer chemoprevention. BMJ (2002) 324 714-718.
10. Lynch T.J., Adjei A.A., Bunn P.A. Jr et al. Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents. Clin. Cancer Res. (2006) 12 4365s-4371s.
11. Sporn M.B. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. (1976) 36 2699-2702.
12. Stoner G.D., Morse M.A., Kelloff G.J. Perspectives in cancer chemoprevention. Environ. Health Perspect. (1997) 105 945-954.
13. Hecht S.S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect. (1997) 105 955-963.
14. You M., Bergman G. Preclinical and clinical models of lung cancer chemoprevention. Hematol. Oncol. Clin. N. Am. (1998) 12 1037-1053.
15. Wang H.Z., Yu C.H., Gao J., Zhao G.R. Effects of processing and extracting methods on active compounds in radix scutellariae by HPLC analysis. Zhongguo Zhang Yao Za Zhi. (2007) 32 1637-1640.
16. Tang W., Eisenbrand G. Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine, Springer, Berlin, 1992, pp. 919.
17. Waller G.R., Chiang Su Medical College. Dictionary of Chinese Crude Drugs, in: The alkaloids-chemistry and physiology. Shanghai Scientific Technological publishers, Shanghai, 1977, pp 2017.
18. Huang W.H., Lee A.R., Chien P.Y. Synthesis of baicalein derivatives as potential anti-aggregator and anti-inflammatory agents. J. Pharm. Pharmacol. (2005) 57 219-225.
19. Hwang J.M., Tseng T.H., Tsai Y.Y. et al. Protective effects of baicalein on tert-butyl hydroperoxide-induced hepatic toxicity in rat hepatocytes. J. Biomed. Sci. (2005) 12 389-397.
20. Ma S.C., Du J., But P.P. et al. Anti-viral Chinese medicinal herbs against respiratory syncytial virus. J. Ethnopharmacol. (2002) 79 205-211.
21. Miocinovic R., McCabe N.P., Keck R.W., Jankun J., Hampton J.A., Selman S.H. In vivo and in vitro effect of baicalein on human prostate cancer cells. Int. J. Oncol. (2005) 26 241-246.
22. Sekiya K., Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem. Biophys. Res. Commun. (1982) 105 1090-1095.
23. Wolfgang B., Klaus H., Brigitte M. Assessing 12 (S) lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem. Tox. (2006) 45 508-514.
24. Hyunju C., Ho-Youl L., Dae-Ro A. et al. Baicalein induces functional hypoxia-inducible factor-1α and angiogenesis. Mol. Pharmacol. (2008) 74 70-81.
25. Kamaraj S., Vinodhkumar R., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T. The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene. Biol. Pharm. Bull. (2007) 30 2268-2273.
26. Foley J.F., Anderson M.W., Stoner G.D., Gaul B.W., Hardisty J.F., Maronpot R.R. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp. Lung Res. (1991) 17 157-168.
27. Zhang Z., Wang Y., Yao R. et al. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models. Oncogene (2004) 23 3841-3850.
28. Estensen R.D., Jordan M.M., Wiedmann T.S., Galbraith A.R., Steele V.E., Wattenberg L.W. Effect of chemopreventive agents on separate stages of progression of benzo[α]pyrene induced lung tumors in A/J mice. Carcinogenesis (2003) 25 197-201.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. (1951) 193 265-275.
30. Bergmeyer H.U. Principles of Enzymatic Analysis, in: Methods of enzymatic analysis. 3rd edn. Vrlag Chemie, Deerfield Beach FL. 1984, pp 135-136.
31. Buening M.K., Chang R.L., Huang M.T., Fortner J.G., Wood A.W., Conney A.H. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally accruing flavonoids. Cancer Res. (1981) 41 67-72.
32. Orlowski M., Meister A. Isolation of γ-Glutamyl transpeptidase from Hog Kidney. J. Biol. Chem. (1965) 240 338-347.
33. Luly P., Barnabei O., Tria E. Hormonal control in vitro of plasma membrane-bound (Na+-K+)-ATPase of rat liver. Biochim. Biophys. Acta (1972) 282 447-452.
34. King J. The Dehydrogenases or Oxidoreductases, Lactate dehydrogenase, in: Van Nostrand D. (Ed), Practical clinical enzymology, Company Ltd, London, 1965, pp. 83-93.
35. Parajuli P., Joshee N., Rimando A.M., Mittal S., Yadav A.K. In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids. Planta Med. (2009) 75 41-48.
36. Magesh V., Singh J.P., Selvendiran K., Ekambaram G., Sakthisekaran D. Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol. Cell. Biochem. (2006) 287 127-135.
37. Das R.K., Banerjee S., Bhattacharya S. Amelioration of benzo(a)pyrene-induced lung carcinogenesis in strain A mice by diphenylmethyl selenocyanate. Exp. Toxicol. Pathol. (2007) 58 351-360.
38. Franklin W.A. Pathology of lung cancer. J. Thorac. Imaging (2000) 15 3-12.
39. Taniguchi H., Yoshida T., Horinaka M. et al. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res. (2008) 68 8918-8927.
40. Im H.I., Nam E., Lee E.S., Hwang Y.J., Kim Y.S. Baicalein Protects 6-OHDA-induced Neuronal Damage by Suppressing Oxidative Stress. Korean J Physiol Pharmacol. (2006) 10(6) 309-315.
41. Franklin W.A. Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. Chest (2000) 117 S80-S89.
42. Chon H., Lee S., Son S.W., Oh C.H., Choo J. Highly sensitive immunoassay of lung cancer marker carcinoembryonic antigen using surface-enhanced Raman scattering of hollow gold nanospheres. Anal. Chem. (2009) 81 3029-3034.
43. Molina R., Filella X., Auge J.M. et al. Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumour Biol. (2003) 24 209-218.
44. Lake B.G. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. Toxicol. Lett. (1995) 83 673-681.
45. Singh S.V., Benson P.J., Hu X. et al. Gender-related differences in susceptibility of A/J mouse to benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis. Cancer Lett. (1998) 128 197-204.
46. Banerjee S., Panda C.Kr., Das S. Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis (2006) 27 1645-1654.
47. Banerjee S., Das S. Chemopreventive efficacy of black tea on benzo(a)pyrene induced lung carcinogenesis. Int. J. Cancer Prev. (2004) 1 129-136.
48. Mumbarkar P.P., Raste A.S., Ghadge M.S. Significance of tumor markers in lung cancer. Indian J. Clin. Biochem. (2006) 21 173-176.
49. Anandakumar P., Kamaraj S., Jagan S. et al. Capsaicin alleviates the imbalance in xenobiotic metabolizing enzymes and tumor markers during experimental lung tumorigenesis. Mol. Cell. Biochem. (2009) 331 135-143.
50. Broers J.L., Ramaekers F.C., Rot M.K. et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res. (1988) 48 3221-3229.
51. Barlesi F., Gimenez C., Torre J.P. et al. Prognostic value of combination of CYFRA 21-1, CEA and NSE in patients with advanced non small cell lung cancer. Respir. Med. (2004) 98 357-362.
52. Ferrigno D., Buccheri G., Biggi A. Serum tumour markers in lung cancer: history, biology and clinical applications. Eur. Respir. J. (1994) 7 186-197.
53. Hecht S.S. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new. Carcinogenesis (2005) 26 1488-1492.
54. Amir M., Tie-juan M., Yang X., Rodney E.K., Jiang-Fan C., Michael R.B. Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. (2007) 293 L753-L761.
55. Kocic G., Djordjevic V., Vlahovic P., Kocic R., Pavlovic D., Jevtovic T. Antioxidants modulate adenosine metabolism in rat mesangial cells cultured under high glucose conditions. Ren. Fail. (2002) 24 691-701.
56. Jagan S., Ramakrishnan G., Anandakumar P., Kamaraj S., Devaki T. Antiproliferative potential of gallic acid against diethylnitrosoamine-induced rat hepatocellular carcinoma. Mol. Cell. Biochem. (2008) 319 51-59.
57. Jean J.C., Liu Y., Brown L.A., Mare R.E., Klings E., Joyce-Brady M. γ-Glutamyl transferase deficiency results in lung oxidant stress in normoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. (2002) 283 L766-L776.
58. Kamaraj S., Ramakrishnan G., Anandakumar P., Jagan S., Devaki T. Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Invest. New Drugs (2008) 27 214-222.
59. Reis M.J. Nucleotidase and its relation to the deamination of nucleotides in the heart and the muscles. Bull. Soc. Chim. Biol. (1934) 16 385-399.
60. Dao T.L., Ip C., Patel J. Serum sialyltransferase and 5′-nucleotidase as reliable biomarkers in women with breast cancer. J. Natl Cancer Inst. (1980) 65 529-534.
61. Anbarasi K., Sabitha K.E., Devi C.S.S. Lactate dehydrogenase isoenzyme patterns upon chronic exposure to cigarette smoke: protective effect of bacoside A. Environ. Toxicol. Pharmacol. (2005) 20 345-350.
62. Engan T., Hannisdal E. Blood analyses as prognostic factors in primary lung cancer. Acta Oncol. (1990) 29 151-154.
63. Ramakrishnan G., Augustine T.A., Jagan S., Vinodhkumar R., Devaki T. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Exp. Oncol. (2007) 29 39-44.